Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
SZSE:301130.SZ
28.32 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 190.679 | 334.37 | 202.78 | 148.63 | 107.736 | 101.397 | 115.888 | 93.354 | 11.698 | 38.651 | 54.04 | 49.064 |
| Short Term Investments
| 84.926 | 215.91 | 413.168 | 65 | 68.366 | 50.4 | 0 | 0 | 0 | 47.429 | 0 | 0 |
| Cash and Short Term Investments
| 275.605 | 547.518 | 615.948 | 213.63 | 107.736 | 101.397 | 115.888 | 93.354 | 11.698 | 38.651 | 54.04 | 49.064 |
| Net Receivables
| 61.392 | 49.143 | 56.785 | 0 | 56.593 | 56.128 | 48.109 | 53.762 | 0 | 0 | 0 | 0 |
| Inventory
| 27.973 | 27.362 | 20.702 | 26.576 | 20.195 | 21.568 | 24.562 | 18.535 | 14.032 | 19.171 | 17.912 | 18.089 |
| Other Current Assets
| 7.94 | 5.524 | 10.739 | 0 | 83.979 | 57.786 | 5.738 | 4.382 | 30.136 | 52.014 | 38.366 | 31.481 |
| Total Current Assets
| 372.91 | 633.763 | 704.172 | 314.929 | 268.503 | 236.88 | 194.297 | 170.033 | 55.866 | 109.836 | 110.318 | 98.634 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 507.791 | 371.644 | 267.937 | 240.97 | 242.188 | 253.983 | 262.549 | 256.742 | 154.973 | 114.739 | 116.875 | 116.4 |
| Goodwill
| 30.569 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 99.849 | 25.575 | 26.625 | 27.676 | 28.726 | 22.805 | 24.863 | 26.939 | 5.556 | 5.879 | 5.962 | 5.803 |
| Goodwill and Intangible Assets
| 130.418 | 25.575 | 26.625 | 27.676 | 28.726 | 22.805 | 24.863 | 26.939 | 5.556 | 5.879 | 5.962 | 5.803 |
| Long Term Investments
| 0 | -2.762 | 0 | 2.276 | 2.589 | 2.902 | 3.215 | 3.528 | 60.313 | 0 | 0 | 0 |
| Tax Assets
| 7.918 | 7.588 | 7.851 | 7.899 | 8.15 | 8.766 | 11.114 | 9.506 | 5.952 | 6.606 | 6.027 | 6.397 |
| Other Non-Current Assets
| 43.538 | 31.388 | 10.418 | 0.855 | 0.604 | 5.423 | 5.599 | 4.079 | 1.418 | 47.429 | 0 | 0 |
| Total Non-Current Assets
| 689.666 | 433.433 | 312.831 | 279.677 | 282.257 | 293.879 | 307.34 | 300.794 | 228.212 | 174.652 | 128.864 | 128.6 |
| Total Assets
| 1,062.576 | 1,067.196 | 1,017.003 | 594.606 | 550.76 | 530.759 | 501.637 | 470.827 | 284.078 | 284.489 | 239.182 | 227.234 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 42.431 | 28.455 | 6.116 | 6.236 | 8.656 | 4.804 | 4.627 | 17 | 6.615 | 13.558 | 14.349 | 17.571 |
| Short Term Debt
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 10 |
| Tax Payables
| 3.204 | 0.484 | 11.171 | 5.894 | 5.2 | 4.158 | 4.347 | 7.524 | 4.379 | 5.083 | 2.82 | 15.961 |
| Deferred Revenue
| 0 | 0 | 6.303 | 3.298 | 4.452 | 3.694 | 7.068 | 0 | 0 | 0 | 8.134 | 17.779 |
| Other Current Liabilities
| 23.471 | 24.76 | 21.449 | 22.559 | 25.924 | 33.236 | 37.453 | 25.562 | 3.131 | 19.948 | 5.946 | 5.305 |
| Total Current Liabilities
| 79.105 | 53.698 | 38.736 | 34.689 | 39.78 | 42.198 | 46.427 | 50.086 | 14.125 | 38.589 | 33.116 | 48.837 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 0.076 | 0.198 | 0 | 0 | 0 | 0 | 0 | 0 | 3.5 | 3.5 | 0 | 0 |
| Deferred Revenue Non-Current
| 37.124 | 29.614 | 32.697 | 35.779 | 38.861 | 41.943 | 45.025 | 39.795 | 37.402 | 39.912 | 36.204 | 0 |
| Deferred Tax Liabilities Non-Current
| 5.106 | 0.743 | 0.281 | 0 | 0 | 0 | 0 | 0 | 0.047 | 0.064 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 8 | 43.224 |
| Total Non-Current Liabilities
| 42.306 | 30.634 | 32.978 | 35.779 | 38.861 | 41.943 | 45.025 | 39.795 | 40.949 | 51.476 | 44.204 | 43.224 |
| Total Liabilities
| 121.412 | 84.333 | 71.714 | 70.468 | 78.641 | 84.141 | 91.452 | 89.881 | 55.074 | 90.064 | 77.32 | 92.062 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 80.804 | 80.804 | 80.804 | 60.603 | 60.603 | 60.603 | 60.603 | 60.603 | 54.133 | 54.133 | 54.133 | 54.133 |
| Retained Earnings
| 391.716 | 375.727 | 343.211 | 317.064 | 270.247 | 249.72 | 218.749 | 193.645 | 106.219 | 76.617 | 48.54 | 25.502 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 66.105 | 61.048 | 146.471 | 141.269 | 136.295 | 130.833 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 433.227 | 394.122 | 521.275 | 146.471 | 141.269 | 136.295 | 130.833 | 126.697 | 68.652 | 63.675 | 59.189 | 55.537 |
| Total Shareholders Equity
| 905.746 | 982.863 | 945.29 | 524.138 | 472.119 | 446.618 | 410.185 | 380.946 | 229.003 | 194.424 | 161.861 | 135.172 |
| Total Equity
| 941.164 | 982.863 | 945.29 | 524.138 | 472.119 | 446.618 | 410.185 | 380.946 | 229.003 | 194.424 | 161.861 | 135.172 |
| Total Liabilities & Shareholders Equity
| 1,062.576 | 1,067.196 | 1,017.003 | 594.606 | 550.76 | 530.759 | 501.637 | 470.827 | 284.078 | 284.489 | 239.182 | 227.234 |